UNITED THERAPEUTICS CORPORATION

Trading Ideas United Therapeutics Corporation

Equities

UTHR

US91307C1027

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 21:00:00 12/12/2025 GMT			5-day change	1st Jan Change
493.99 ^USD	+1.12%		+0.96%	+40.00%

12-10	United Therapeutics Insider Sold Shares Worth $3,833,374, According to a Recent SEC Filing	MT
12-09	United Therapeutics Insider Sold Shares Worth $10,050,597, According to a Recent SEC Filing	MT

Trading Ideas

UNITED THERAPEUTICS CORPORATION: Close to an important technical resistance levels	11-17
UNITED THERAPEUTICS CORPORATION: Attractive price levels	15/02/24
UNITED THERAPEUTICS CORPORATION: There is still some upside potential	01/03/21
UNITED THERAPEUTICS CORPORATION: The technical configuration is positive	15/12/20
UNITED THERAPEUTICS CORPORATION: Perfect timing to aim a technical rebound	05/02/16
UNITED THERAPEUTICS CORPORATION: Back to the USD 64 for a new impetus	02/05/13

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

United Therapeutics delivers 18th consecutive quarter of topline growth

United Therapeutics delivers 18th consecutive quarter of topline growth

June 17, 2025 at 08:39 am

All transcripts on over 9000 companies, on the day they post their earnings!

Unlock them now!

Unlock them now!